bg-title

To request article copies, email us at This email address is being protected from spambots. You need JavaScript enabled to view it..

Nguyen C, Xie L, Alley S, Baser O, Wang Z. Epidemiology and economic burden of serotonin syndrome with concomitant use of serotonergic agents: a retrospective study utilizing two large US claims databases. Prim Care Companion CNS Disord. Forthcoming 2017.

Black CM, Fillit H, Xie L, Hu X, Kariburyo MF, Ambegaonkar BM, Baser O, Yuce H, Khandker RK. Economic burden, mortality and institutionalization in patients newly diagnosed with Alzheimer’s disease. J Alzheimers Dis. Forthcoming 2017.

Bent-Ennakhil N, Coste F, Xie L, Sanon Aigbogun M, Wang Y, Kariburyo F, Hartry A, Baser O, Neumann P, Fillit H. A real-world analysis of treatment patterns for cholinesterase inhibitors and memantine among newly-diagnosed Alzheimer’s disease patients. Neurol Ther. 2017;6(1):131-144.

Yıldırım T, Altınbas A, Aydınlı M, Ersoy O, Bayraktar Y. Is central pontine myelinolysis a sign of pre-symptomatic neurologic form of Wilson disease? Turk J Gastroenterol. 2012;23(4):419-20.

Thompson JM, Luedtke CA, Oh TH, Shah ND, Long KH, King S, Branda M, Swanson R. Direct medical costs in patients with fibromyalgia: Cost of illness and impact of a brief multidisciplinary treatment program. Am J Phys Med Rehabil. 2011;90(1):40-6.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L. Risperidone treatment in elderly dementia patients: Relative risk of cardiovascular adverse events versus other antipsychotic. Int Psychogeriati. 2005;17(4):1-13.

To request article copies, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it..